1. Black JW, Leff P: Operational models of pharmacological agonist. Proc R Soc Lond [Biol]. 1983, 220: 141-16. 10.1098/rspb.1983.0093. 2
2. Roth BL, Chuang D-M: Multiple mechanisms of serotonergic signal transduction. Life Sci. 1987, 41: 1051-1064. 10.1016/0024-3205(87)90621-7.
3. Mailman RB, Lawler CP, Lewis MM, Blake B: Functional effects of novel dopamine ligands: Dihydrexidine and Parkinson’s disease as a first step. Dopamine Receptor Subtypes: From Basic Science to Clinical Application. Edited by: Jenner P, Demirdamar R. 1998, IOS Press, New York, 53-65.
4. Roerig SC, Loh HH, Law PY: Identification of three separate guanine nucleotide- binding proteins that interact with the δ-opioid receptor in NG108-15 X glioma hybrid cells. Mol. Pharmacol. 1992, 41: 822.831-
5. Fisher A, Heldman E, Gurwitz D, Haring R, Barak D, Meshulam H, Marciano D, Brandeis R, Pittel Z, Segal M: Selective signaling via unique M1 muscarinic agonists. Ann N Y Acad Sci. 1993, 695: 300-303. 10.1111/j.1749-6632.1993.tb23070.x.